Skip to content

Evaluation of the AS76 with PBS device for Peripheral Blood Smear Examination.

Clinical Evaluation of AS76 with PBS versus light microscopy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091408
Enrollment
200
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R70-R79- Abnormal findings on examination of blood, without diagnosis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

SigTuple Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study is an all comers study that shall include samples from healthy individuals and samples from individuals with various hematological conditions and distributional abnormalities such as anemia, thrombocytopenia, leukopenia, leukocytosis, elevated hematocrit, elevated nucleated red blood cells, leukemia, etc. The abnormal samples shall align with the recommendations of the CLSI H20-A2 standard. Samples from both genders shall be used. Samples from individuals belonging to any race/ethnicity can be used.

Exclusion criteria

Exclusion criteria: The following sample exclusion criteria shall be applied - 1. Slides that are not prepared adequately shall be excluded from the study. For example slides that are not smeared well or are stained poorly. 2. Slides that have been prepared from degenerated blood and are considered unsuitable for evaluation by the qualified reviewers after examination under a light microscope (as per the standard procedures of the laboratory). 3. Slides considered unsuitable for evaluation by the qualified reviewers after examination under light microscope (as per the laboratory s standard procedures).

Design outcomes

Primary

MeasureTime frame
Agreement between AS76 with PBS and light microscopy in evaluating white blood cell (WBC), red blood cell (RBC), and platelet (PLT) morphologies. For WBCs: Passing-Bablok regression (slope, intercept, bias) will be used for differential counts. Sensitivity, specificity, and overall agreement will be calculated for detecting WBC abnormalities. For RBCs and PLTs: sensitivity, specificity, and overall agreement for morphological abnormalities. Timepoint: The outcomes will be analyzed 3 months from the date of study initiation.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactTathagato Rai Dastidar

Sigtuple Technologies Private Limited

trd@sigtuple.com9036839020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026